FRA
INSM icon

Frank Rimerman Advisors’s Insmed INSM Stock Holding History

Frank Rimerman Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$277K Buy
+1,697
New +$261K 0.02% 517

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Frank Rimerman Advisors's INSM Position: Q1 2026 in Review

Frank Rimerman Advisors opened a new position in Insmed (INSM) in Q1 2026: 1,697 shares worth $277K. The stake represents 0.02% of the portfolio and ranks #517 among its holdings.

669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Frank Rimerman Advisors held 1,697 shares of Insmed worth $277K as of Q1 2026.
  • Insmed was a new Frank Rimerman Advisors position in Q1 2026.
  • Insmed made up 0.02% of Frank Rimerman Advisors's portfolio in Q1 2026, its #517 holding.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.